Stay informed with the latest updates for the inheritable blood disorders community.

          Industry
          Janssen's HCV Therapy Receives FDA Priority Review
          Industry
          Bayer Discontinues rFVIIa Therapy Trial
          Advocacy & Legislative
          ACA Implementation Activity, NHF Advocacy Continues
          Industry
          Antiviral Oral Combination Treats Certain HCV Patients
          Advocacy & Legislative
          Affordable Care Act Implementation Continues
          Industry
          Achillion Drug Begins Phase 2 Trial in HCV Patients
          Industry
          Gilead Announces HCV Drug Sofosbuvir Clinical Trial Results
          Advocacy & Legislative
          President Releases 2014 Budget Proposal
          Industry
          CSL Donates to WFH GAP Program
          Medical
          Seaweed Derivative Promotes Clotting in Hemophilia Patients
          NBDF & Community
          NHF Announces Chapter Grant Award Recipients
          Medical
          NGC Accepts WFH's Hemophilia Management Guidelines
          Industry
          Baxter Submits FDA Application for Prophylactic FEIBA for Inhibitor…
          Medical
          Hepatitis Researcher to Receive Canadian Award
          Medical
          Pediatric Organization Urges Ruling Out Bleeding Disorders…